NRX Pharmaceuticals (NRXP) Total Debt (2018 - 2025)
NRX Pharmaceuticals (NRXP) posted quarterly Total Debt of $152000.0 for Q3 2025, down 76.03% year-over-year from $634000.0 in Q3 2024, and down 59.79% quarter-over-quarter from $378000.0 in Q2 2025.
NRX Pharmaceuticals (NRXP) Total Debt (2018 - 2025) Analysis & Trends
NRX Pharmaceuticals (NRXP) has reported Total Debt for 7 consecutive years, with $152000.0 the latest figure, recorded in Q3 2025.
- In Q3 2025, Total Debt fell 76.03% year-over-year to $152000.0; the TTM figure through Sep 2025 stood at $152000.0 (down 76.03% YoY), while the FY2024 annual figure was $320000.0, changed N/A from the prior year.
- Total Debt eased to $152000.0 in Q3 2025 per NRXP's latest filing, from $378000.0 in the prior quarter.
- Across five years, Total Debt topped out at $26.3 million in Q3 2021 and bottomed at $152000.0 in Q3 2025.
- Historically, Total Debt has averaged $6.3 million across 4 years, with a median of $1.2 million in 2021.
- Annual changes were most pronounced in 2021 — Total Debt surged 3367.17% — and 2025, when it slumped 76.03%.
- NRX Pharmaceuticals' Total Debt stood at $4.6 million in 2021, then plunged by 45.9% to $2.5 million in 2022, then sank by 87.09% to $320000.0 in 2024, then tumbled by 52.5% to $152000.0 in 2025.
- Business Quant data shows NRXP's Total Debt at $152000.0 in Q3 2025, $378000.0 in Q2 2025, and $320000.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 1.99 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 591.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 1.07 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 770.36 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 546.77 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 9.34 Bn |
| 10 | NRX Pharmaceuticals | 132.53 Mn | 105.83 Mn | 426,000.00 | 412,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 152,000.00 |
| Jun 30, 2025 | 378,000.00 |
| Dec 31, 2024 | 320,000.00 |
| Sep 30, 2024 | 634,000.00 |
| Jun 30, 2024 | 943,000.00 |
| Mar 31, 2022 | 2.48 Mn |
| Dec 31, 2021 | 4.58 Mn |
| Sep 30, 2021 | 26.28 Mn |
| Jun 30, 2021 | 25.87 Mn |
| Mar 31, 2021 | 1.38 Mn |
| Sep 30, 2020 | 758,060.00 |
| Jun 30, 2020 | 1.67 Mn |
| Mar 31, 2020 | 1.63 Mn |
| Dec 31, 2019 | 416,141.00 |
| Sep 30, 2019 | 327,198.00 |
| Jun 30, 2019 | 1.38 Mn |
| Mar 31, 2019 | 1.49 Mn |
| Dec 31, 2018 | 690,000.00 |